Abstract:Key PointsCRISPR–Cas (clustered regularly interspaced short palindromic repeats–CRISPR-associated proteins) is an adaptive immune system in bacteria and archaea, which is categorized into three distinct types (known as type I, type II and type III) that differ in their compositions and mechanisms of action. Adaptive immunity occurs in three distinct stages: acquisition, expression and interference.In all three types of CRISPR–Cas system, spacer acquisition relies on a pair of conserved Cas proteins (Cas1 and Cas2), which are probably assisted by a variable set of additional (potentially both Cas and non-Cas) enzymes.Primary processing of CRISPR RNAs (crRNAs) is catalysed either by Cas6-like ribonucleases (in the type I and type III systems) or by RNase III (which targets the crRNA and transactivating crRNA (tracrRNA) duplex in type II systems).Mature crRNAs form CRISPR ribonucleoprotein (crRNP) complexes by associating with either Cascade-like multiprotein complexes (in type I and type III systems) or the multidomain Cas9 protein (in type II systems).Discrimination of 'self' nucleic acid from 'non-self' nucleic acid enables crRNP complexes to specifically target invading nucleic acid (usually DNA). Some complexes recruit additional nucleases (for example, Cas3 in type I systems), whereas other crRNPs have intrinsic nuclease domains (for example, Cas9 in type II systems).Fundamental studies have elucidated many mechanistic features of CRISPR–Cas functionality by integrating genetics, biochemistry and structural biology. This has provided an excellent basis for developing a wide range of applications, from the manipulation of gene expression in bacteria to genome editing in eukaryotes.

Structural and functional insights into the type III-E CRISPR-Cas immunity

Target RNA activates the protease activity of Craspase to confer antiviral defense

Structural basis for the non-self RNA-activated protease activity of the type III-E CRISPR nuclease-protease Craspase

Structure and function of a bacterial type III-E CRISPR–Cas7-11 complex

Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas

Target RNA-guided protease activity in type III-E CRISPR–Cas system

Unravelling the structural and mechanistic basis of CRISPR–Cas systems

Structure and mechanism of the type I-G CRISPR effector

Bioinformatic analysis of type III CRISPR systems reveals key properties and new effector families

Assembly of multi-subunit fusion proteins into the RNA-targeting type III-D CRISPR-Cas effector complex

Structural basis of Cas3 activation in type I-C CRISPR-Cas system

Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex

Structural and mechanistic insights into inhibition of the type I-F CRISPR-Cas surveillance complex by AcrIF4

The structural biology of CRISPR-Cas systems

Structure Principles of CRISPR-Cas Surveillance and Effector Complexes

Type III CRISPR-Cas System: Introduction and Its Application for Genetic Manipulations.

Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Structural insight into the Csx1-Crn2 fusion self-limiting ribonuclease of type III CRISPR system

Type III-B CRISPR-Cas signaling-based cascade of proteolytic cleavages

Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins

Molecular Mechanisms Of Iii-B Crispr-Cas Systems In Archaea